These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

516 related items for PubMed ID: 3314916

  • 1. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
    Nishi K, Kondo T, Narabayashi H.
    No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
    [Abstract] [Full Text] [Related]

  • 2. A simple quantitative bradykinesia test in MPTP-treated mice.
    Ogawa N, Hirose Y, Ohara S, Ono T, Watanabe Y.
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):435-41. PubMed ID: 3878557
    [Abstract] [Full Text] [Related]

  • 3. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P, Marsden CD.
    J Neural Transm Suppl; 1986 Dec; 20():11-39. PubMed ID: 3091760
    [Abstract] [Full Text] [Related]

  • 4. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK, Keyghobadi M, Moore C, Meshul CK.
    Neuroscience; 2005 Dec; 136(1):333-41. PubMed ID: 16198485
    [Abstract] [Full Text] [Related]

  • 5. The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Burns RS, LeWitt PA, Ebert MH, Pakkenberg H, Kopin IJ.
    N Engl J Med; 1985 May 30; 312(22):1418-21. PubMed ID: 2581135
    [Abstract] [Full Text] [Related]

  • 6. FGF-2 in the MPTP model of Parkinson's disease: effects on astroglial cells.
    Otto D, Unsicker K.
    Glia; 1994 May 30; 11(1):47-56. PubMed ID: 8070894
    [Abstract] [Full Text] [Related]

  • 7. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.
    Mizukawa K, Ogawa N, Sora YH.
    Res Commun Chem Pathol Pharmacol; 1988 Jan 30; 59(1):121-8. PubMed ID: 3258432
    [Abstract] [Full Text] [Related]

  • 8. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F, Alessandrì MG, Torracca MT, Bassi L, Corsini GU.
    J Pharmacol Exp Ther; 1997 Oct 30; 283(1):100-7. PubMed ID: 9336313
    [Abstract] [Full Text] [Related]

  • 9. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the substantia nigra and the locus coeruleus in BALB/c mice.
    Hu SC, Chang FW, Sung YJ, Hsu WM, Lee EH.
    J Pharmacol Exp Ther; 1991 Dec 30; 259(3):1379-87. PubMed ID: 1684822
    [Abstract] [Full Text] [Related]

  • 10. De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset.
    Pearce RK, Banerji T, Jenner P, Marsden CD.
    Mov Disord; 1998 Mar 30; 13(2):234-41. PubMed ID: 9539335
    [Abstract] [Full Text] [Related]

  • 11. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains.
    Haobam R, Sindhu KM, Chandra G, Mohanakumar KP.
    Behav Brain Res; 2005 Sep 08; 163(2):159-67. PubMed ID: 15941598
    [Abstract] [Full Text] [Related]

  • 12. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
    Date I, Asari S, Nishimoto A, Felten DL.
    No To Shinkei; 1990 Nov 08; 42(11):1035-40. PubMed ID: 2076347
    [Abstract] [Full Text] [Related]

  • 13. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y.
    Eur J Neurosci; 2009 Mar 08; 29(5):891-900. PubMed ID: 19245369
    [Abstract] [Full Text] [Related]

  • 14. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L, Frohna PA, Joyce JN, Schneider JS.
    Mov Disord; 1997 Mar 08; 12(2):148-58. PubMed ID: 9087972
    [Abstract] [Full Text] [Related]

  • 15. [Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].
    Lange KW.
    Fortschr Neurol Psychiatr; 1989 Apr 08; 57(4):142-8. PubMed ID: 2656447
    [Abstract] [Full Text] [Related]

  • 16. Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy).
    Stefanova N, Puschban Z, Fernagut PO, Brouillet E, Tison F, Reindl M, Jellinger KA, Poewe W, Wenning GK.
    Acta Neuropathol; 2003 Aug 08; 106(2):157-66. PubMed ID: 12764627
    [Abstract] [Full Text] [Related]

  • 17. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment.
    Schneider JS.
    J Neurosci Res; 1992 Jan 08; 31(1):112-9. PubMed ID: 1613817
    [Abstract] [Full Text] [Related]

  • 18. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Doudet D, Gross C, Lebrun-Grandié P, Bioulac B.
    C R Seances Soc Biol Fil; 1985 Jan 08; 179(1):85-97. PubMed ID: 3161601
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of 1-ethyl- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridines on catecholamine concentrations in mouse brain and heart.
    Fuller RW, Hemrick-Luecke SK, Robertson DW.
    Res Commun Chem Pathol Pharmacol; 1988 Jan 08; 59(1):129-32. PubMed ID: 3258433
    [Abstract] [Full Text] [Related]

  • 20. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
    Drolet RE, Behrouz B, Lookingland KJ, Goudreau JL.
    Neurotoxicology; 2004 Sep 08; 25(5):761-9. PubMed ID: 15288507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.